SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Introgen Therapeutics
INGN 7.000-0.4%Nov 7 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (289)5/8/2005 12:11:46 PM
From: zeta1961 of 802
 
Tumor Suppressor P53 Inhibits Replication Of Hepatitis C Virus Subgenomic Replicon in Human Hepatoma Cells

[from browsing Digestive Week abstracts, if this can be accomplished in the clinic..diez casas en Barcelona<g>]

Authors: N. Dharel, N. Kato, H. Taniguchi, M. Otsuka, M. Moriyama, R. Muroyama, Y. Wang, R. Shao, T. Kawabe, M. Omata

Abstract ID: 524


Background & Aims: Chronic hepatitis C virus (HCV) infection is a major cause of liver cirrhosis and hepatocellular carcinoma worldwide. Host cellular factors regulating HCV replication are still to be elucidated.



Methods: 1) Naive Huh7 cells and Huh7-168 (high replication permissive Huh7 cells), were transfected with subgenomic HCV replicon and their replication permissiveness was compared. 2) p53 expression among high or low-replication permissive cells was examined by Western blot. 3) p53 expression in Huh7 cells non-permissive to HCV replicon was silenced by siRNA, and the p53 knocked down cells were transfected with HCV replicon. 4) p53 overexpressing plasmid or p53 silencing plasmid were co-transfected with HCV replicon into Huh7-168, and colony formation assay was performed. 5) p53 overexpressing plasmid was transfected into replicon harboring cells, and immunofluorescence staining of p53 and HCV NS5A was performed. 6) p53 mutant with point mutation at cell cycle regulating or apoptosis regulating residue was constructed, and their effect on HCV replication was compared to that of the wild type p53.



Results: 1) Numerous neomycin resistant colonies were obtained from Huh7-168 but no colony was obtained from naïve Huh7 cells. 2) Higher-replication supporting cells (confirmed by Western blotting for NS5B and real time RT-PCR) had a tendency of lower p53 expression. 3) Following p53 silencing, replication non-permissive naïve Huh7 cells supported a high level replication of HCV replicon. 4) p53 overexpression reduced the number of colonies, whereas p53 silencing increased. 5) HCV NS5A expression was low in cells overexpressing p53, whereas high expression of HCV NS5A was seen in p53 knocked down cells. 6) Mutant p53 with point mutation at cell cycle regulating or apoptosis regulating residue suppressed HCV replication as well as the wild type.



Conclusions: p53 inhibits HCV replication independent of cell cycle arrest and apoptotic function. Exploration of the mechanism of this hitherto unrecognized link between p53 and HCV could enhance the understanding of HCV replication, and could lead to the development of better therapeutic options.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext